Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival

SIMPLE SUMMARY: A cohort of 153 melanoma patients treated with immune checkpoint inhibitors as first line therapy were studied, to specifically describe the timelines of all adverse events by the target organ, demonstrating a different profile of appearance over time. Interestingly, the survival ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Villa-Crespo, Lorena, Podlipnik, Sebastian, Anglada, Natalia, Izquierdo, Clara, Giavedoni, Priscila, Iglesias, Pablo, Dominguez, Mireia, Aya, Francisco, Arance, Ana, Malvehy, Josep, Puig, Susana, Carrera, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909485/
https://www.ncbi.nlm.nih.gov/pubmed/35267545
http://dx.doi.org/10.3390/cancers14051237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909485/
https://www.ncbi.nlm.nih.gov/pubmed/35267545
http://dx.doi.org/10.3390/cancers14051237

Ejemplares similares